Vladimir Arias-Mulens

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

A roadmap for systematic humanization of a chimeric antigen receptor: preclinical validation of a humanized CD22 scFv as a model.

A roadmap for systematic humanization of a chimeric antigen receptor: preclinical validation of a humanized CD22 scFv as a model.

Journal: Experimental hematology

Published: November 20, 2025

CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemia.

CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemia.

Journal: Journal of hematology & oncology

Published: November 05, 2024

CAR-T cell therapy for cancer: current challenges and future directions.

CAR-T cell therapy for cancer: current challenges and future directions.

Journal: Signal transduction and targeted therapy

Published: October 07, 2024

Validation of ZIP4 as a tumour-associated antigen for nanotargeting.

Validation of ZIP4 as a tumour-associated antigen for nanotargeting.

Journal: Journal of drug targeting

Published: September 16, 2024

Biocompatible Iron Oxide Nanoparticles Display Antiviral Activity Against Two Different Respiratory Viruses in Mice.

Biocompatible Iron Oxide Nanoparticles Display Antiviral Activity Against Two Different Respiratory Viruses in Mice.

Journal: International journal of nanomedicine

Published: April 25, 2024

Cationic Polyethyleneimine (PEI)-Gold Nanocomposites Modulate Macrophage Activation and Reprogram Mouse Breast Triple-Negative MET-1 Tumor Immunological Microenvironment.

Cationic Polyethyleneimine (PEI)-Gold Nanocomposites Modulate Macrophage Activation and Reprogram Mouse Breast Triple-Negative MET-1 Tumor Immunological Microenvironment.

Journal: Pharmaceutics

Published: September 26, 2022

Different coatings on magnetic nanoparticles dictate their degradation kinetics in vivo for 15 months after intravenous administration in mice.

Different coatings on magnetic nanoparticles dictate their degradation kinetics in vivo for 15 months after intravenous administration in mice.

Journal: Journal of nanobiotechnology

Published: September 23, 2022

Iron oxide and iron oxyhydroxide nanoparticles impair SARS-CoV-2 infection of cultured cells.

Iron oxide and iron oxyhydroxide nanoparticles impair SARS-CoV-2 infection of cultured cells.

Journal: Journal of nanobiotechnology

Published: May 06, 2022

The surface coating of iron oxide nanoparticles drives their intracellular trafficking and degradation in endolysosomes differently depending on the cell type.

The surface coating of iron oxide nanoparticles drives their intracellular trafficking and degradation in endolysosomes differently depending on the cell type.

Journal: Biomaterials

Published: September 17, 2021

Multiphoton imaging of melanoma 3D models with plasmonic nanocapsules.

Multiphoton imaging of melanoma 3D models with plasmonic nanocapsules.

Journal: Acta biomaterialia

Published: August 19, 2021

The Use of Iron Oxide Nanoparticles to Reprogram Macrophage Responses and the Immunological Tumor Microenvironment.

The Use of Iron Oxide Nanoparticles to Reprogram Macrophage Responses and the Immunological Tumor Microenvironment.

Journal: Frontiers in immunology

Published: April 11, 2021

Tumor-Selective Immune-Active Mild Hyperthermia Associated with Chemotherapy in Colon Peritoneal Metastasis by Photoactivation of Fluorouracil-Gold Nanoparticle Complexes.

Tumor-Selective Immune-Active Mild Hyperthermia Associated with Chemotherapy in Colon Peritoneal Metastasis by Photoactivation of Fluorouracil-Gold Nanoparticle Complexes.

Journal: ACS nano

Published: February 02, 2021

Showing 1-12 of 21

Last Updated: 09/26/2026